Literature DB >> 9621015

Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity.

J Le Seyec1, P Chouteau, I Cannie, C Guguen-Guillouzo, P Gripon.   

Abstract

Among the three viral proteins present in the hepatitis B virus (HBV) envelope, both the small and large polypeptides, but not the middle polypeptide, are necessary for the production of complete viral particles. Whereas it has been established that the C-terminal extremity of the pre-S1 region is required for HBV morphogenesis, whether the pre-S2 region of the large surface protein plays a critical role remains questionable. In the present study, we have analyzed the role of the large-polypeptide pre-S2 region in viral maturation and infectivity. For this purpose, mutants bearing contiguous deletions covering the entire pre-S2 domain were generated. First, the efficient expression of all the mutant large envelope proteins was verified and their ability to substitute for the wild-type form in virion secretion was tested. We found that distinct deletions covering the domain between amino acids 114 and 163 still allowed virion production. In contrast, the polypeptide lacking the first 5 amino acids of pre-S2 (amino acids 109 to 113) was unable to support viral secretion. This result shows that the domain of the large surface protein, required for this process, must be extended to the N-terminal extremity of pre-S2. We then demonstrated that all the mutants competent for virion release were able to infect normal human hepatocytes in primary culture. Taken together, these results indicate that only 10% of the large-protein pre-S2 region at its N-terminal extremity is essential for virion export and that the remaining part, dispensable for viral secretion, is also dispensable for infectivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621015      PMCID: PMC110210     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum.

Authors:  K Kuroki; R Russnak; D Ganem
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

2.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

7.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.

Authors:  F Poisson; A Severac; C Hourioux; A Goudeau; P Roingeard
Journal:  Virology       Date:  1997-02-03       Impact factor: 3.616

9.  Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide.

Authors:  P Gripon; C Diot; N Thézé; I Fourel; O Loreal; C Brechot; C Guguen-Guillouzo
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more
  40 in total

1.  Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.

Authors:  Seoung-Ae Lee; Ki-Jeong Kim; Dong-Won Kim; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

2.  Determination of the minimal distance between the matrix and transmembrane domains of the large hepatitis B virus envelope protein.

Authors:  Britta Kluge; Michaela Schläger; Alexander Pairan; Volker Bruss
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 3.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.

Authors:  Severin Gudima; Anja Meier; Roland Dunbrack; John Taylor; Volker Bruss
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation.

Authors:  Dirk Ponsel; Volker Bruss
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Authors:  Andreas Schulze; Alexa Schieck; Yi Ni; Walter Mier; Stephan Urban
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

7.  Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain.

Authors:  J Le Seyec; P Chouteau; I Cannie; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity.

Authors:  Charlotte Lepère; Morgane Régeard; Jacques Le Seyec; Philippe Gripon
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

10.  Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.

Authors:  Tamako Garcia; Jisu Li; Camille Sureau; Kiyoaki Ito; Yanli Qin; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.